Oncology Segment

News across the web »
Interact & exchange stock tips & market info »
Related News »
The company also has an animal health business segment. Eli Lilly and Company will present data from several molecules that make up its clinical oncology pipeline during the 48th Annual Meeting of the ASCO 2012. Lilly's early-stage pipeline molecules will ...
May 24, 2012 at 15:58 | Source: Seekingalpha.com
The company's flagship product is Tarceva, a small molecule inhibitor of the epidermal growth factor receptor (EGFR) in the Oncology segment. The company's product pipeline include Erlotinib tablets, OSI-906, OSI-027, OSI-930 for oncology, PSN821 ...
May 12, 2012 at 08:12 | Source: Transworld News
It bought 2 Mn shares for around Rs.350 per share. Established in 1987, Shilpa Medicare is a bulk drug manufacturing company, focuses on manufacturing API for the niche Oncology segment. It has long term contracts to supply APIs to international ...
May 23, 2012 at 05:50 | Source: dealcurry.com
Fine Chemicals segment revenues increased 28% and 40% in the Fiscal 2012 ... The increases in anti-viral products revenues were offset somewhat by lower volume in oncology products revenues. Our largest legacy oncology product is an active pharmaceutical ...
May 11, 2012 at 19:12 | Source: GuruFocus
It also has an "Other" segment, which comprises the Varian Particle Therapy ... cycles and further penetration in under-equipped international markets. In Oncology Systems, Varian introduced the TrueBeam system for image guided radiotherapy ...
May 15, 2012 at 23:54 | Source: NASDAQ
The retail segment is the largest and most profitable part of the US ... which would come from fondaparinux if we were to keep the oncology and fondaparinux assets together. What is rationale behind the proposed demerger? How will it potentially affect ...
May 23, 2012 at 10:29 | Source: 4-traders (press release)
The report will enhance your decision-making capability. - It will allow you to understand the scope of success of Xgeva that would give a competitive edge to the company and increase its market share in the oncology segment.
May 11, 2012 at 17:17 | Source: Transworld News
The company, which manufactures medical devices used in infusion therapy, oncology, and critical care applications ... and its oncological-products segment shows that it's capable of so much more than just the 5.7% sales growth it exhibited ...
May 11, 2012 at 23:58 | Source: Motley Fool
It also has an “Other” segment, which comprises the Varian Particle Therapy ... cycles and further penetration in under-equipped international markets. In Oncology Systems, Varian introduced the TrueBeam system for image guided radiotherapy ...
May 16, 2012 at 21:01 | Source: Yahoo Finance
Segment EBITDA was $2.0 million compared to $2.2 million ... The increases in anti-viral products revenues were offset somewhat by lower volume in oncology products revenues.  Our largest legacy oncology product is an active pharmaceutical ...
May 9, 2012 at 19:57 | Source: Sacramento Bee